Neogenomics (NEO) Income towards Parent Company (2010 - 2026)
Neogenomics (NEO) reported Income towards Parent Company of -$17.1 million for Q1 2026, up 34.01% on a YoY basis from -$12.8 million in Q1 2025, and down 73.12% quarter-over-quarter from -$9.9 million in Q4 2025.
Neogenomics (NEO) Income towards Parent Company (2010 - 2026) Analysis & Trends
Neogenomics has reported Income towards Parent Company for 17 years, with the latest figure at -$17.1 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company rose 34.01% year-over-year to -$17.1 million; the trailing twelve-month figure through Mar 2026 stood at -$99.2 million (down 27.87% YoY), and the FY2025 full-year result was -$108.0 million, down 37.22% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$17.1 million, down from -$9.9 million in the prior quarter.
- The five-year high for Income towards Parent Company was -$9.9 million in Q4 2025, with the low at -$49.4 million in Q1 2022.
- Historically, Income towards Parent Company has averaged -$25.7 million across 5 years, with a median of -$24.3 million in 2023.
- Annual changes were most pronounced in 2022 — Income towards Parent Company tumbled 146.53% — and 2023, when it soared 49.76%.
- Neogenomics' Income towards Parent Company stood at -$22.7 million in 2022, then jumped by 36.85% to -$14.3 million in 2023, then decreased by 6.97% to -$15.3 million in 2024, then soared by 35.52% to -$9.9 million in 2025, then sank by 73.12% to -$17.1 million in 2026.
- The last three Income towards Parent Company figures came in at -$17.1 million (Q1 2026), -$9.9 million (Q4 2025), and -$27.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.11 Mn |
| Dec 31, 2025 | -9.88 Mn |
| Sep 30, 2025 | -27.13 Mn |
| Jun 30, 2025 | -45.09 Mn |
| Mar 31, 2025 | -25.92 Mn |
| Dec 31, 2024 | -15.32 Mn |
| Sep 30, 2024 | -17.70 Mn |
| Jun 30, 2024 | -18.64 Mn |
| Mar 31, 2024 | -27.06 Mn |
| Dec 31, 2023 | -14.33 Mn |
| Sep 30, 2023 | -18.52 Mn |
| Jun 30, 2023 | -24.33 Mn |
| Mar 31, 2023 | -30.80 Mn |
| Dec 31, 2022 | -22.69 Mn |
| Sep 30, 2022 | -36.85 Mn |
| Jun 30, 2022 | -35.30 Mn |
| Mar 31, 2022 | -49.41 Mn |
| Dec 31, 2021 | -41.76 Mn |
| Sep 30, 2021 | -20.35 Mn |
| Jun 30, 2021 | 75.87 Mn |